Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2.
Liu N, Liu M, Jiang M, Li Z, Chen W, Wang W, Fu X, Qi M, Ali MH, Zou N, Liu Q, Tang H, Chu S.
Liu N, et al. Among authors: qi m.
Biomed Pharmacother. 2023 Mar;159:114173. doi: 10.1016/j.biopha.2022.114173. Epub 2023 Jan 19.
Biomed Pharmacother. 2023.
PMID: 36680814
Free article.